| 查看: 1068 | 回复: 5 | ||
| 【奖励】 本帖被评价5次,作者lwjxz增加金币 4 个 | ||
[资源]
2011.07.21~22生物利用度/生物等效性(BA/BE)国际高级研习班(苏州)资料--1 PDF版
|
||
|
下载:http://ishare.iask.sina.com.cn/f/17812763.html 培训班授课专家 1. Gordon Amidon Ph.D., College of Pharmacy, University of Michigan, USA Dr. Gordon L. Amidon received his B.S. degree from the State University of New York, Buffalo (1967), an M.A. degree in Mathematics (1970) and Ph.D. in Pharmaceutical Chemistry (1971) from The University of Michigan. From 1971 to 1981 Dr. Amidon was a member of the faculty at the University of Wisconsin. Dr. Amidon was appointed Professor of Pharmaceutics at The University of Michigan in 1983 and was named the Charles R. Walgreen, Jr., Professor of Pharmacy in 1994. Dr. Amidon is internationally known for his research in the field of drug absorption, transport phenomena, solubility and dissolution, and prodrugs. He has published extensively in journals, with over 300 published papers and 370 abstracts, 18 US patents, contributed chapters to over 30 books and monographs and is co-editor of eight books. Professor Amidon has mentored over 80 doctoral and postdoctoral students with more than 20 selecting academic careers. He has received numerous awards including; best paper awards in the Journal of Pharmaceutical Sciences (1975, 1981, 1984) and Pharmaceutical Research (2004); the Scheele Award of the Swedish Academy of Pharmaceutical Sciences for outstanding contributions to the field of oral drug delivery and biopharmaceutics (1996). He received an honorary Doctor of Pharmacy degree from the University of Uppsala, Sweden (2001); the Founders Award of the Controlled Release Society (2003); the Volwiler Award of the American Association of Colleges of Pharmacy (2004); the AAPS Distinguished Pharmaceutical Scientist Award (2005); the FIP Distinguished Pharmaceutical Scientist Award (2006), the Gerhard Levy Distinguished Lectureship (2006), the Alexander von Humboldt Research Award (2009), and the Japan Society for the Promotion of Science (JSPS) Award (2011). He has organized and participated in many international symposia and workshops. Dr. Amidon developed a Biopharmaceutics Classification System (BCS), with the FDA, impacting bioequivalence standards worldwide. He is a Fellow of the AAPS, APhA/APS, and the AAAS. He is a member of the Controlled Release Society, serving as president in 1994, AACP, ACS and AAPS, serving as president in 1998. Professor Amidon is the editor of the American Chemical Society Journal, Molecular Pharmaceutics. |
» 猜你喜欢
求助几篇文献
已经有3人回复
黄体酮有关物质|4 类常见降解反应溯源小结
已经有0人回复
药物学论文润色/翻译怎么收费?
已经有69人回复
【讨论】美罗培南杂质,不愧是培南里的难题大户,踩坑太多了
已经有1人回复
【讨论】利托那韦,做有关物质的同行来聊聊,这个品种到底有多难啃?
已经有0人回复
布瑞哌唑稳定性踩坑,这个品种光敏性真的顶不住!
已经有0人回复
齐拉西酮杂质研究,简直就是在玩打地鼠
已经有0人回复
反应机理
已经有5人回复
【交流】伯舒替尼杂质谱梳理与质控几点踩坑,欢迎补充
已经有0人回复
甲基变羧基
已经有3人回复
» 本主题相关价值贴推荐,对您同样有帮助:
芬兰奥卢大学生物中心招聘公派联合培养,公派读博,访问学者和相关学生
已经有14人回复
6楼2015-03-29 16:37:32
简单回复
2011-08-06 17:59
回复
五星好评
lrwy3楼
2011-08-06 21:28
回复
五星好评 





News4楼
2011-08-06 21:46
回复
五星好评
小樱桃5楼
2012-08-06 11:12
回复
五星好评 顶一下!!










回复此楼